https://www.selleckchem.com/pr....oducts/Temsirolimus.
bstetrical patients with COVID-19 symptoms and exposures is feasible and resulted in rates of ambulatory management similar to those seen in nonpregnant patients. A centralized model for telemedicine surveillance of obstetrical patients with COVID-19 symptoms may preserve inpatient resources and prevent avoidable staff and patient exposures, particularly in centers with multiple ambulatory practice settings. A multidisciplinary telemedicine surveillance model for outpatient management of obstetrical patients with COVID-19 symptoms
Like
Comment
Share
